Clinical Trial Update: Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether tailoring dual antiplatelet therapy to the extent of platelet inhibition improves outcomes in patients with unsta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction
• Unstable Angina

Snippet

Sponsor: University of Florence | Conditions: Unstable Angina, NSTEMI | Phase 3 | Status: UNKNOWN